PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
27694161-4	2016	Erlotinib, a selective EGFR inhibitor, enhanced AQP2 apical membrane expression in collecting duct principal cells and reduced urine volume by 45% after 5 days of treatment in mice with lithium-induced NDI.	Erlotinib Hydrochloride	0-9	aquaporin 2	Mus musculus	48-52	
27694161-6	2016	Erlotinib increased phosphorylation of AQP2 at Ser-256 and Ser-269 and decreased phosphorylation at Ser-261 in a dose-dependent manner.	Erlotinib Hydrochloride	0-9	aquaporin 2	Mus musculus	39-43	
34156031-7	2021	Treatment with Erlotinib, a tyrosine kinase inhibitor promoting exocytosis and inhibiting endocytosis, normalized the expression level and membrane abundance of Aqp2 protein, and partially rescued the water reabsorption defect observed in the Pdcd10-deficient mice.	Erlotinib Hydrochloride	15-24	aquaporin 2	Mus musculus	161-165